See the DrugPatentWatch profile for Adasuve
Adasuve, also known by its generic name, loxapine, is an inhaled medication approved for the acute treatment of agitation in adults with schizophrenia or bipolar I disorder [1]. It is a dibenzoxazepine antipsychotic [2].
How does Adasuve work for agitation?
Adasuve delivers loxapine directly to the lungs, allowing for rapid absorption into the bloodstream and quick onset of action [1]. The exact mechanism by which loxapine reduces agitation is not fully understood, but it is believed to involve antagonism of dopamine D2 and serotonin 5-HT2A receptors in the brain [2].
What are the risks associated with Adasuve?
The primary safety concern with Adasuve is the risk of bronchospasm, which can be serious and potentially life-threatening [1]. Because of this risk, Adasuve should only be administered in a healthcare setting where patients can be monitored for at least three hours after dosing and where emergency resuscitation equipment is available [3]. Patients with respiratory conditions such as asthma or COPD may be at increased risk [1]. Other potential side effects include somnolence and changes in taste [2].
When does Adasuve's patent expire?
Information regarding the specific patent expiry dates for Adasuve (loxapine) can be found on DrugPatentWatch.com [4]. Patent protection is crucial for drug manufacturers, influencing market exclusivity and the potential for generic competition.
Can loxapine be used for other conditions?
While Adasuve is specifically approved for acute agitation, loxapine in other formulations has been used historically for the management of schizophrenia. Its use in other indications is generally off-label and not specifically addressed by the Adasuve approval [1, 2].
What are the alternatives to Adasuve for agitation?
Other treatment options for acute agitation in schizophrenia and bipolar disorder may include oral or injectable antipsychotics, benzodiazepines, or a combination of medications. The choice of treatment depends on individual patient factors, the severity of agitation, and the healthcare setting [1].
What is the pricing and accessibility of Adasuve?
Pricing and accessibility information for Adasuve can vary based on insurance coverage, pharmacy, and geographic location. Detailed cost information is typically available through healthcare providers and pharmacies [4].
Sources:
1. Adasuve prescribing information.
2. Loxapine.
3. FDA approves Adasuve (loxapine) inhalation powder for acute agitation.
4. DrugPatentWatch.com